Vilanterol Impurity 45 | CAS 208925-08-0 - Request Quote
Vilanterol Impurity 45
| SZ CAT No: | SZ-V031054 |
| CAS No | 208925-08-0 |
| Mol.F. | C12H17NO3 |
| Mol.Wt. | 223.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Vilanterol Impurity 45 is chemically (R)-2-Amino-1-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)ethan-1-ol. Vilanterol Impurity 45 is supplied with detailed characterization data compliant with regulatory guideline. Vilanterol Impurity 45 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vilanterol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 208925-08-0
Purchase 208925-08-0
Order 208925-08-0
Enquire 208925-08-0
price of 208925-08-0
208925-08-0 Supplier
208925-08-0 Manufacturer
208925-08-0 Exporter
buy high quality Vilanterol Impurity 45
Purchase Vilanterol Impurity 45
Vilanterol Impurity 45 suppliers
Vilanterol Impurity 45 manufacturers
Vilanterol Impurity 45 price
Order Vilanterol Impurity 45
Enquire Vilanterol Impurity 45
Vilanterol Impurity 45 cost
Vilanterol Impurity 45 Supplier
Vilanterol Impurity 45 Distributor
Vilanterol Impurity 45 for Method Validation
Vilanterol Reference Standard
Vilanterol Impurity 45 for ANDA Filing
Vilanterol Impurity 45 for Forced Degradation Studies
Vilanterol Impurity 45 Identification Standards
Vilanterol Impurity 45 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.